Charles River Laboratories International Company Profile (NYSE:CRL)

Analyst Ratings

Consensus Ratings for Charles River Laboratories International (NYSE:CRL) (?)
Ratings Breakdown: 2 Sell Rating(s), 4 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $82.40 (6.14% downside)

Analysts' Ratings History for Charles River Laboratories International (NYSE:CRL)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016Credit Suisse Group AGInitiated CoverageNeutral$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyCorpReiterated RatingHold$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016Barclays PLCBoost Price TargetUnderweight$60.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016GabelliInitiated CoverageBuy$96.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingBuy$96.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Bank of America Corp.Reiterated RatingBuy$90.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Goldman Sachs Group Inc.Boost Price TargetSell$71.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Deutsche Bank AGReiterated RatingHold$85.00 -> $82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Robert W. BairdBoost Price TargetOutperform$86.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Citigroup Inc.Reiterated RatingHold$75.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Morgan StanleyReiterated RatingEqual Weight$65.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Edward JonesUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015SunTrust Banks Inc.UpgradeNeutral -> Buy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Cantor FitzgeraldReiterated RatingBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Charles River Laboratories International (NYSE:CRL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2016Q116$0.90$0.98$354.92 million$354.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q415$0.94$1.00$349.20 million$353.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.94$1.03$340.09 million$349.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.97$0.96$338.30 million$339.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115$0.82$0.79$324.00 million$320.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$0.72$0.81$318.73 million$329.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.80$0.86$326.70 million$327.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214$0.82$0.97$327.96 million$341.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114$0.74$0.82$302.08 million$299.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2014Q413$0.68$0.73$289.56 million$289.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.70$0.79$290.28 million$292.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.71$0.73$293.77 million$294.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.71$0.69$294.53 million$291.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q4 2012$0.60$0.64$280.81 million$280.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012$0.62$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.66$0.75ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.65$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2012$0.56$0.69ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.58$0.57ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.60$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.55$0.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2011$0.50$0.60ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Charles River Laboratories International (NYSE:CRL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20169$0.84$0.95$0.91
Q2 20166$1.09$1.13$1.11
Q3 20165$1.13$1.17$1.15
Q4 20166$1.06$1.19$1.14
Q1 20172$1.18$1.36$1.27
Q2 20172$1.21$1.23$1.22
Q3 20171$1.30$1.30$1.30
Q4 20171$1.31$1.31$1.31
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Charles River Laboratories International (NYSE:CRL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Charles River Laboratories International (NYSE:CRL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/1/2016George MassaroDirectorSell3,740$83.09$310,756.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016John J CrowleyCAOSell1,913$85.00$162,605.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Richard F WallmanDirectorSell1,970$82.32$162,170.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Richard F WallmanDirectorSell11,990$84.00$1,007,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016George MassaroDirectorSell985$82.17$80,937.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Richard F WallmanDirectorSell2,720$81.00$220,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Davide MolhoVPSell30,667$80.00$2,453,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Nancy GillettVPSell7,015$75.00$526,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Nancy GillettVPSell3,646$73.50$267,981.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016David P JohstVPSell34,075$73.02$2,488,156.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016James C FosterCEOSell3,873$70.40$272,659.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016George M Milne JrDirectorSell10,440$73.02$762,328.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016James C FosterCEOSell9,831$73.12$718,842.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016C Richard ReeseDirectorSell4,228$71.48$302,217.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Nancy GillettVPSell6,750$71.90$485,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Stephen D ChubbDirectorSell2,000$74.76$149,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015George MassaroDirectorSell7,740$80.00$619,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Thomas F. AckermaninsiderSell10,000$80.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Thomas F. AckermaninsiderSell10,000$75.00$750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Thomas F. AckermaninsiderSell21,612$70.01$1,513,056.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Stephen D ChubbDirectorSell2,000$66.57$133,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Thomas F AckermanInsiderSell5,000$75.53$377,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Thomas F AckermanCFOSell3,900$70.51$274,989.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015George MassaroDirectorSell1,360$70.21$95,485.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Stephen D ChubbDirectorSell2,000$75.52$151,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Deborah Turner KochevarDirectorSell2,600$76.59$199,134.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015James C FosterCEOSell2,036$76.93$156,629.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Nancy GillettVPSell4,379$76.72$335,956.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Nancy GillettVPSell2,772$76.95$213,305.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015James C FosterCEOSell4,621$75.96$351,011.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Nancy GillettVPSell5,015$76.12$381,741.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015James C FosterCEOSell4,800$75.70$363,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Jorg GellerVPSell12,061$76.17$918,686.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015James C FosterCEOSell8,423$76.56$644,864.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015Jorg GellerVPSell7,041$76.59$539,270.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015George M Milne JrDirectorSell6,000$75.87$455,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015James C FosterCEOSell9,671$75.00$725,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Stephen D ChubbDirectorSell5,011$73.97$370,663.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Jorg GellerVPSell14,430$73.54$1,061,182.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Thomas F AckermanCFOSell4,400$73.50$323,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Davide MolhoVPSell19,075$74.00$1,411,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Jorg GellerVPSell8,458$73.68$623,185.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Thomas F AckermanCFOSell10,000$70.00$700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2015David P JohstVPSell4,737$67.00$317,379.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015David P JohstVPSell26,100$65.00$1,696,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Stephen D ChubbDirectorSell2,000$64.44$128,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014David P JohstVPSell6,982$65.34$456,203.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Thomas F AckermanCFOSell10,000$63.70$637,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Jorg GellerVPSell5,610$63.57$356,627.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2014C Richard ReeseDirectorSell5,849$63.39$370,768.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014John J CrowleyCAOSell1,000$64.00$64,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Davide MolhoVPSell16,402$64.54$1,058,585.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014George MassaroDirectorSell16,710$65.00$1,086,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Thomas F AckermanCFOSell36,100$65.00$2,346,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Nancy GillettVPSell1,069$65.00$69,485.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014David P JohstVPSell74,780$64.00$4,785,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014James C FosterCEOSell136,647$62.00$8,472,114.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Thomas F AckermanCFOSell5,000$60.00$300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Davide MolhoVPSell4,900$61.34$300,566.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Stephen D ChubbDirectorSell2,000$59.18$118,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014George MassaroDirectorSell10,440$60.00$626,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Thomas F AckermanCFOSell23,156$59.25$1,371,993.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Richard F WallmanDirectorSell3,240$58.20$188,568.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Stephen D ChubbDirectorSell2,000$52.93$105,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Deborah Turner KochevarDirectorSell3,100$53.30$165,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014George MassaroDirectorSell1,620$52.70$85,374.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Thomas AckermanCFOSell5,430$50.76$275,626.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Nancy GillettVPSell10,110$58.36$590,019.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Nancy GillettVPSell13,650$58.98$805,077.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Stephen ChubbDirectorSell2,000$58.70$117,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Jorg GellerVPSell7,486$59.41$444,743.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Nancy GillettVPSell4,000$60.00$240,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Jorg GellerVPSell3,188$58.49$186,466.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Nancy GillettVPSell4,000$58.96$235,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Stephen ChubbDirectorSell5,198$58.35$303,303.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Thomas AckermanCFOSell14,000$58.05$812,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014David JohstVPSell19,750$58.00$1,145,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014George MassaroDirectorSell5,750$54.00$310,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Thomas AckermanCFOSell5,000$52.72$263,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Jorg GellerVPSell7,200$51.93$373,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Stephen ChubbDirectorSell2,000$51.92$103,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013George MassaroDirectorSell5,958$47.38$282,290.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013James C FosterCEOSell174,479$47.00$8,200,513.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Thomas F AckermanCFOSell6,100$46.13$281,393.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Stephen ChubbDirectorSell2,000$46.49$92,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013James FosterCEOSell40,983$47.00$1,926,201.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013Davide MolhoVPSell6,500$47.93$311,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Stephen ChubbDirectorSell4,000$47.46$189,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Jorg GellerVPSell3,025$46.38$140,299.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Richard WallmanDirectorSell1,500$45.95$68,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Davide MolhoVPSell4,100$45.89$188,149.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Deborah Turner KochevarDirectorSell4,447$46.02$204,650.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Thomas AckermanCFOSell26,250$46.03$1,208,287.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Thomas F AckermanCFOSell4,000$42.40$169,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013James C FosterCEOSell113,810$45.00$5,121,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013George MassaroDirectorSell2,020$44.09$89,061.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2013David P JohstVPSell17,038$45.00$766,710.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Charles River Laboratories International (NYSE:CRL)
DateHeadline
07/22/16 09:50 AMEarnings Focus and Crowd Sourced Sentiment Review for Charles River Laboratories International, Inc. (NYSE:CRL) - TGP
07/22/16 09:50 AMFox Run Management L.l.c. adds Charles River Laboratories (CRL) to its portfolio - Trade Calls
07/21/16 04:58 AMShares Positive Over the Past Month: Charles River Laboratories International, Inc. (NYSE:CRL) - TGP
07/21/16 04:58 AMAre Analysts Bullish Charles River Laboratories Intl. Inc (NYSE:CRL) After Last Week? - Press Telegraph
07/21/16 04:58 AMQuick View of Earnings: Charles River Laboratories International, Inc. (NYSE:CRL), Catalent, Inc. (NYSE:CTLT ... - Engelwood Daily
07/21/16 04:58 AMStock Strength in Focus for Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/21/16 04:58 AMIs $97 Price Target Attainable For Charles River Laboratories International, Inc. (NYSE:CRL)? - Investor Newswire
07/19/16 08:45 PMCharles River Laboratories International, Inc. (NYSE:CRL) Broker Price Targets For The Coming Week - Fiscal Standard
07/19/16 08:45 PMLong Term Value Play: Charles River Laboratories International, Inc. (NYSE:CRL) - TGP
07/19/16 08:45 PMCharles River Laboratories International, Inc. (NYSE:CRL): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/18/16 03:36 PMReview on Stock Valuation for: Charles River Laboratories International, Inc. (NYSE:CRL) - TGP
07/18/16 03:36 PMShare Performance Summary for: Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/15/16 07:28 PMCrowd Rating and Earnings Recap for Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/15/16 07:28 PMConsensus Target and Stock Rating Report: Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/15/16 07:28 PMCharles River Laboratories International, Inc. (NYSE:CRL) Updated Price Targets - FTSE News
07/13/16 03:30 PMCharles River Laboratories International, Inc. (NYSE:CRL) Quarterly Dividend Was $-1.357 Millions - Stocks Daily
07/12/16 08:49 PMAnalyst Target and Average Rating Watch: Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/12/16 08:49 PMCharles River Laboratories International, Inc. (NYSE:CRL) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 08:49 PMShare Strength Review for Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/12/16 08:49 PMCharles River Laboratories International Inc Realized Volatility Hits a Dropping Level - CML News
07/12/16 07:43 AMShares Positive on the Year: Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/12/16 07:43 AMCharles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call - Yahoo Finance
07/11/16 03:53 PMCharles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call - [at noodls] - WILMINGTON, Mass.--(BUSINESS WIRE)--Jul. 11, 2016-- Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2016 financial results on Wednesday, August 3 before the market ...
07/11/16 08:11 AMStock Rating Watch and Earnings Insight for Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/10/16 03:14 PMStock Performance Rundown on: Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
07/10/16 03:14 PMNext Weeks Broker Price Targets For Charles River Laboratories International, Inc. (NYSE:CRL) - Fiscal Standard
07/09/16 04:58 AMCharles River Laboratories International (CRL) : Analyst Rating Update - Trade Calls
07/06/16 03:30 PMLong Term Growth Stock: Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/04/16 03:11 PMShares With YTD Gains: Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/04/16 03:11 PMBroker Outlook For The Week Ahead Charles River Laboratories International, Inc. (NYSE:CRL) - Fiscal Standard
07/04/16 07:24 AMCharles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : July 4, 2016 -
07/03/16 08:01 AMDo Institutional Investors Love Charles River Laboratories International Inc (NYSE:CRL)? - Press Telegraph
07/03/16 08:01 AMStock Valuation in Review: Charles River Laboratories International, Inc. (NYSE:CRL) - Telanagana Press
07/01/16 09:58 AMCharles River Laboratories International, Inc. (NYSE:CRL) Company Rating and Target Watch - Telanagana Press
06/30/16 03:41 PMCharles River Laboratories International, Inc. (NYSE:CRL) Quarterly Dividend Payout At $-1.357 Millions - Stocks Daily
06/30/16 02:40 PMETF’s with exposure to Charles River Laboratories International, Inc. : June 30, 2016 -
06/30/16 10:26 AMCharles River CEO: 'Companies that don’t grow, die'
06/28/16 03:23 PMCovering the Bases on Charles River Laboratories International, Inc. (NYSE:CRL): Where is the Stock Going? - Press Telegraph
06/28/16 03:23 PMShares in Decline this Year Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/28/16 03:23 PMMost Active Mix Cap Movers- Charles River Laboratories International (NYSE:CRL), Monsanto (NYSE:MON), Relypsa ... - Seneca Globe
06/28/16 03:23 PMCharles River Laboratories (CRL) Announces Acquisition of Blue Stream Laboratories - StreetInsider.com
06/28/16 08:17 AMCharles River Laboratories (CRL) Announces Acquisition of Blue Stream Laboratories
06/27/16 07:57 AMStock Performance Focus on: Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/27/16 07:57 AMShare Update and Earnings Review for Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/23/16 02:16 PMNew Broker Ratings For Charles River Laboratories International, Inc. (NYSE:CRL) - FTSE News
06/22/16 08:39 PMCharles River Laboratories (NYSE:CRL) target price upped to $84, reported today by Credit Suisse
06/22/16 03:34 PMCharles River Laboratories International, Inc. (NYSE:CRL) Annual Accrued Expenses At $162.326 Millions - Stocks Daily
06/21/16 03:16 PMCharles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage - TheStreet.com
06/21/16 01:22 PMCharles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage -
06/21/16 10:23 AMCharles River Laboratories International, Inc. – Value Analysis (NYSE:CRL) : June 21, 2016 -

Social

About Charles River Laboratories International

Charles River Laboratories International logoCharles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services (RMS), which consists of Research Models and Research Model Services; Discovery and Safety Assessment (DSA), which offers discovery and safety assessment services, both regulated and non-regulated, in which it includes both in vivo and in vitro studies, and Manufacturing Support (Manufacturing), which includes Microbial Solutions, Biologics Testing Solutions and Avian Vaccine Services. It has developed a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, which is able to support its clients from target identification through preclinical development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: CRL
  • CUSIP: 15986410
Key Metrics:
  • Previous Close: $87.79
  • 50 Day Moving Average: $84.04
  • 200 Day Moving Average: $79.18
  • P/E Ratio: 27.01
  • P/E Growth: 1.62
  • Market Cap: $4.14B
  • Beta: 1.29
  • Current Year EPS Consensus Estimate: $4.39 EPS
  • Next Year EPS Consensus Estimate: $5.02 EPS
Additional Links:
Charles River Laboratories International (NYSE:CRL) Chart for Wednesday, July, 27, 2016